Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1871-1880 of 2919 for cancer

Edit search filters
  1. TAS-102 And Radiation Therapy In Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, Or Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Testing The Addition Of High Dose, Targeted Radiation To The Usual Treatment For Locally-Advanced Inoperable Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Cetuximab With Or Without Tivantinib In Treating Patients With Head And Neck Cancer That Is Recurrent, Metastatic, Or Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Study Of Pembrolizumab (MK-3475) Compared To Platinum-Based Chemotherapies In Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)

    Rochester, MN

  5. Targeted Treatment For Advanced Non-Small Cell Lung Cancer That Has Increased Copies Of The MET Gene (An Expanded Lung-MAP Treatment Trial)

    Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate The Effectiveness And Safety Of Rivaroxaban As Prophylaxis Treatment For Venous Thromboembolism (VTE) In Ambulatory Cancer Patients

    Rochester, MN

  7. A Clinical Study Of MK-1084 With Targeted Therapy And Chemotherapy In People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study Of ASP8273 Versus Erlotinib Or Gefitinib As First-Line Treatment For Patients With Stage IIIB/IV Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study Of Pembrolizumab Alone Or Combined With CC-486 For Patients With Platinum-Resistant Ovarian, Fallopian Tube, Or Peritoneal Cancer

    Rochester, MN

  10. A Study For Women Who Have Platinum Resistant Ovarian Cancer To Evaluate EC145 Combined With Pegylated Liposomal Doxorubicin, Compared To Pegylated Liposomal Doxorubicin Alone

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer